Mark A. Dawson
www.petermac.org
0000-0002-5464-5029
University of Padova
4 papers found
Refreshing results…
CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activity
Clinical MDR1 inhibitors enhance Smac-mimetic bioavailability to kill murine LSCs and improve survival in AML models
Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation
Endogenous retroviruses are a source of enhancers with oncogenic potential in acute myeloid leukaemia
Missing publications? Search for publications with a matching author name.